|
Novel Approach to Enhance Cord Blood-Mediated Bone Marrow Homing and Engraftment
|
1R43CA139602-01
|
$193,658
|
$193,658
|
MILLER, LEONARD
|
AMERICAN STEM CELL, INC.
|
|
Training Patients and Partners for HSCT: A Novel Coping Skills Intervention
|
5R03CA130725-02
|
$84,500
|
$84,500
|
Lawsin, Catalina
|
BERNARD M. BARUCH COLLEGE
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
7R01CA113969-04
|
$316,480
|
$158,240
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
|
Enhancing Activity of Alkylating Agents in Neuroblastoma
|
5R01CA082830-07
|
$210,659
|
$69,517
|
REYNOLDS, CHARLES
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-04
|
$311,617
|
$155,809
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Determinants of Relapse Risk After BMT for ALL
|
5R01CA116660-02
|
$289,644
|
$289,644
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Cancer Center Support Grant
|
2P30CA033572-25
|
$2,342,475
|
$421,646
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S1
|
$95,134
|
$17,124
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S2
|
$107,415
|
$19,335
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
3P01CA030206-26S1
|
$86,513
|
$86,513
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
5P01CA030206-26
|
$2,908,648
|
$2,908,648
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-05
|
$2,163,322
|
$540,831
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A Standardized Nursing Intervention Protocol for HCT Patients
|
5R01CA107446-03
|
$416,424
|
$208,212
|
GRANT, MARCIA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$3,736
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$1,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$4,301
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$349,253
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Rebuilding Immunity for Survival
|
5U19CA100265-05
|
$2,757,436
|
$2,757,436
|
NADLER, LEE
|
DANA-FARBER CANCER INSTITUTE
|
|
GM-CSF secreting tumor cell vaccines to enhance post-transplant anti-CLL immunity
|
1R21CA132232-01
|
$378,360
|
$189,180
|
WU, CATHERINE
|
DANA-FARBER CANCER INSTITUTE
|
|
Functions of E2A in B Lymphocyte Development
|
5R01CA072433-11
|
$310,291
|
$31,029
|
Zhuang, Yuan
|
DUKE UNIVERSITY
|
|
Family Decision Making in Pediatric Bone Marrow Transplant
|
1R21CA131875-01A1
|
$232,705
|
$232,705
|
PENTZ, REBECCA
|
EMORY UNIVERSITY
|
|
Adult Leukemia Research Center
|
3P01CA018029-33S1
|
$140,652
|
$140,652
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Adult Leukemia Research Center
|
5P01CA018029-33
|
$4,943,916
|
$4,943,916
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-30
|
$237,038
|
$94,815
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Immunosupression-Resistant Gene Modified Donor T Cells
|
5R01CA109381-04
|
$323,970
|
$323,970
|
GEORGES, GEORGE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S4
|
$9,979,932
|
$798,395
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S5
|
$60,810
|
$4,865
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S6
|
$264,000
|
$21,120
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Mycophenylate Mofetil for Treatment of Chronic GVHD
|
2R01CA098906-06
|
$382,446
|
$382,446
|
MARTIN, PAUL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Clinical Significance of MHC Haplotypes in HCT
|
2R01CA100019-06
|
$344,520
|
$344,520
|
Petersdorf, Effie
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-21
|
$1,944,619
|
$583,386
|
Press, Oliver
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-10S1
|
$125,023
|
$3,751
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-10S2
|
$193,710
|
$5,811
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
5P30CA076292-10
|
$2,780,246
|
$83,407
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
The Significance of MARCO Expression by Tumor-Pulsed Dendritic Cells
|
5R01CA071669-10
|
$366,750
|
$366,750
|
MULE, JAMES
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Effects of Foxp3-Induced Regulatory T Cells on GVHD and GVT Activity
|
5R01CA118116-03
|
$286,106
|
$286,106
|
YU, XUE-ZHONG
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Stem cell manipulation via HOX gene regulation
|
5R01CA090833-07
|
$280,779
|
$140,390
|
EMERSON, STEPHEN
|
HAVERFORD COLLEGE
|
|
Marrow Infiltrating Lymphocyte Immunotherapy in Myeloma
|
1R21CA130344-01A2
|
$369,000
|
$369,000
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
The role of myeloid suppressor cells in tumor-specific tolerance
|
5R01CA124996-02
|
$311,600
|
$102,828
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Hematopoietic Stem Cells for Transplantation
|
2P01CA070970-10A1
|
$2,035,680
|
$223,925
|
CIVIN, CURT
|
JOHNS HOPKINS UNIVERSITY
|
|
Restoring T Cell Responses to Therapeutic Tumor Vaccines
|
5R01CA105148-04
|
$318,780
|
$318,780
|
FUCHS, EPHRAIM
|
JOHNS HOPKINS UNIVERSITY
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-33
|
$2,910,583
|
$2,910,583
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Augmenting Antitumor Immunity after Allografting
|
1R01CA122779-01A2
|
$291,723
|
$291,723
|
LUZNIK, LEO
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-46
|
$7,420,697
|
$667,863
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Analysis of the STAT3 Pathway In Tumor Tolerance and Immune Evasion
|
5R01CA125192-03
|
$282,659
|
$70,665
|
PARDOLL, DREW
|
JOHNS HOPKINS UNIVERSITY
|
|
In vivo targeted DC vaccine to activate anti-tumor CTL
|
5R01CA112065-04
|
$329,612
|
$329,612
|
CUI, YAN
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
GVL without GVHD across HLA barriers: Translational Studies
|
5P01CA111519-03
|
$1,650,432
|
$825,216
|
Sykes, Megan
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Separation of GVH and GVL in Mouse Models
|
5R01CA079989-09
|
$261,354
|
$261,354
|
Sykes, Megan
|
MASSACHUSETTS GENERAL HOSPITAL
|
Total relevant funding to Bone Marrow Transplantation for this search: $55,539,605
|